FAST NEWS: Fosun Pharma hits pause button on share buyback program
The Latest: Shanghai Fosun Pharmaceutical (Group) Co. Ltd. (2196.HK; 600196.SH) announced Monday it hasn't yet implemented a share buyback since announcing a plan on March 27 to buy back its A shares…
Fosun International on cusp of new ‘asset-light’ era with latest sale
The conglomerate is selling its stake in multinational insurer Ageas, extending a slimming exercise touched off by a liquidity crisis in 2022 Key Takeaways: Fosun International’s total debt-to-capitalization ratio stood…
FAST NEWS: Henlius expects first-ever annual profit on strong drug sales
The latest: Shanghai Henlius Biotech Inc. (2696.HK) said on Monday it expects to report a net profit of 500 million yuan ($69.5 million) or more for 2023, reversing a loss of 695 million…
FAST NEWS: Henlius swings to the black on strong sales growth
The latest: Shanghai Henlius Biotech Inc. (2696.HK) on Wednesday reported a net profit of 408 million yuan ($56.2 million) in the first three quarters of this year, reversing a loss of…
Debt pressures cast cloud over Fosun Pharma results
The drugmaker eked out a 0.16% rise in first-half revenue, but underlying net profit slipped 26% as waning sales of Covid treatments and foreign exchange losses squeezed earnings Key Takeaways:…
CHINA BULLETIN: Weak Economic Signals All Around
In this week’s issue weak signals in trade and inflation, and LinkedIn links out. On a scale of 1 to 100, we give the week a 40 for offshore-listed China stocks.
Fosun Pharma, CanSino take different paths as Covid lift fade
The pair of companies that got strong shots from different Covid vaccines are telling different stories in their latest quarterly results as the pandemic draws down Key Takeaways: Fosun Pharma’s…
Recent Articles
FAST NEWS: Fosun Pharma hits pause button on share buyback program
2196.HK
600196.SHG
Debt pressures cast cloud over Fosun Pharma results
2196.HK
600196.SHG
Fosun Pharma, CanSino take different paths as Covid lift fade
2196.HK
6185.HK
RELATED ARTICLES
-
Debt pressures cast cloud over Fosun Pharma results
2196.HK 600196.SHG
-
Fosun International on cusp of new ‘asset-light’ era with latest sale
0656.HK
-
Fosun Tourism at crossroads as parent shops its two major assets
1992.HK 0656.HK
-
Fosun Tourism embarks on new journey with departure of big-name director
1992.HK
-
Fosun Tourism’s post-Covid holiday fizzles
1992.HK
-
Akeso marks profit milestone with swift rights issue
9926.HK
